Kazia Therapeutics (KZIA)
14.60
+0.45 (3.18%)
Upcoming Events
Latest Headlines
Form 4 KAZIA THERAPEUTICS LTD For: Jan 08 Filed by: Coffey Steven R. S.
July 8, 2026 5:00 PM - SEC Filing
Form 4 KAZIA THERAPEUTICS LTD For: Jan 08 Filed by: Friend John E. II
July 8, 2026 4:59 PM - SEC Filing
Form 4 KAZIA THERAPEUTICS LTD For: Jan 08 Filed by: Bonacorda Jeffrey
July 8, 2026 4:59 PM - SEC Filing
Form 4 KAZIA THERAPEUTICS LTD For: Jan 08 Filed by: Davidson Ebru
July 8, 2026 4:58 PM - SEC Filing
Form 4 KAZIA THERAPEUTICS LTD For: Jan 08 Filed by: Cain David
July 8, 2026 4:58 PM - SEC Filing
Form 4 KAZIA THERAPEUTICS LTD For: Jan 08 Filed by: APPLE ROBERT F
July 8, 2026 4:57 PM - SEC Filing
BTIG Starts Kazia Therapeutics (KZIA) at Buy
July 1, 2026 6:06 AM - StreetInsider
Form 4 KAZIA THERAPEUTICS LTD For: Jun 19 Filed by: Levine James E.
June 23, 2026 6:47 PM - SEC Filing
Form 4 KAZIA THERAPEUTICS LTD For: Jun 19 Filed by: Rao Sudha
June 23, 2026 6:47 PM - SEC Filing
Form 3 KAZIA THERAPEUTICS LTD For: Jun 01 Filed by: Levine James E.
June 15, 2026 6:53 PM - SEC Filing
Lake Street Starts Kazia Therapeutics (KZIA) at Buy
June 11, 2026 8:12 AM - StreetInsider
Form 3 KAZIA THERAPEUTICS LTD For: Mar 18 Filed by: Davidson Ebru
June 3, 2026 8:20 PM - SEC Filing
The Multi-Billion-Dollar Search for Better Glioblastoma Treatments
June 3, 2026 9:29 AM - StreetInsider
Form 424B3 KAZIA THERAPEUTICS LTD
June 2, 2026 9:05 AM - SEC Filing
Form 424B3 KAZIA THERAPEUTICS LTD
June 2, 2026 9:03 AM - SEC Filing
Form 424B3 KAZIA THERAPEUTICS LTD
June 2, 2026 9:02 AM - SEC Filing
Form 424B3 KAZIA THERAPEUTICS LTD
June 2, 2026 9:01 AM - SEC Filing
Form 6-K KAZIA THERAPEUTICS LTD For: Jun 02
June 2, 2026 9:00 AM - SEC Filing
Kazia Therapeutics names James Levine as CFO
June 2, 2026 7:30 AM - StreetInsider
Kazia Therapeutics Appoints James Levine as Chief Financial Officer
June 2, 2026 7:30 AM - PR NewsWire
Form SCHEDULE 13G/A KAZIA THERAPEUTICS LTD Filed by: Chernett Jorey
May 27, 2026 10:32 AM - SEC Filing
Form 424B3 KAZIA THERAPEUTICS LTD
May 26, 2026 8:05 AM - SEC Filing
Form 424B3 KAZIA THERAPEUTICS LTD
May 26, 2026 8:04 AM - SEC Filing
Form 424B3 KAZIA THERAPEUTICS LTD
May 26, 2026 8:03 AM - SEC Filing
Form 424B3 KAZIA THERAPEUTICS LTD
May 26, 2026 8:02 AM - SEC Filing
Form 6-K KAZIA THERAPEUTICS LTD For: May 26
May 26, 2026 8:00 AM - SEC Filing
Kazia Therapeutics expands breast cancer trial enrollment to 36 patients
May 26, 2026 7:30 AM - StreetInsider
Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer
May 26, 2026 7:30 AM - PR NewsWire
Form 3 KAZIA THERAPEUTICS LTD For: Apr 13 Filed by: Rao Sudha
May 19, 2026 1:07 PM - SEC Filing
Form 6-K KAZIA THERAPEUTICS LTD For: Apr 27
April 27, 2026 8:31 AM - SEC Filing
Full Article List